Gainey McKenna & Egleston files class action lawsuit against Mereo

A class action lawsuit has been filed against Mereo, as announced by Gainey McKenna & Egleston. The lawsuit was filed on behalf of investors who purchased Mereo’s securities between February 15, 2019, and November 1, 2021. The lawsuit alleges that Mereo misled investors about the efficacy of its lead product, etigilimab, in treating patients with solid tumors.

During the class period, Mereo made several statements touting the potential of etigilimab as a groundbreaking treatment for solid tumors. However, the lawsuit claims that the company failed to disclose important information about the drug’s development and effectiveness. Specifically, the lawsuit alleges that Mereo did not disclose that etigilimab’s clinical trials were not designed optimally to assess its effectiveness, leading to misleading results.

The lawsuit further alleges that Mereo made false and misleading statements about the drug’s potential for FDA approval and commercial success. As a result of these allegedly misleading statements, investors who purchased Mereo’s securities during the class period suffered financial losses when the truth about etigilimab’s efficacy came to light.

Investors who suffered losses as a result of their investment in Mereo during the class period may be eligible to participate in the class action lawsuit. To be eligible, investors must have purchased Mereo’s securities between February 15, 2019, and November 1, 2021. Investors who wish to participate in the lawsuit should contact Gainey McKenna & Egleston for more information.

Gainey McKenna & Egleston is a law firm specializing in securities litigation. The firm has a track record of successfully representing investors in class action lawsuits against companies that have engaged in securities fraud. If you believe that you have suffered financial losses as a result of Mereo’s alleged securities fraud, you may be entitled to compensation through the class action lawsuit.

The class action lawsuit against Mereo is still in its early stages, and it is important for investors to seek legal advice as soon as possible if they believe they have a claim. By participating in the lawsuit, investors may be able to recover some or all of the financial losses they suffered as a result of Mereo’s alleged misconduct. Contact Gainey McKenna & Egleston today to learn more about your legal options in this class action lawsuit.